Jesse Alt

6PUBLICATIONS
63CO-AUTHORS
Innate immunityGene and molecular therapyImmunogenetics (incl. genetic immunology)Instrumental methods (excl. immunological and bioassay methods)Molecular targets
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (6)

|Aug 09, 2023
A gut-restricted glutamate carboxypeptidase II inhibitor reduces monocytic inflammation and improves preclinical colitis.

Diane E Peters, Lauren D Norris, Lukáš Tenora

|Jul 26, 2023
Preclinical Efficacy of LP-184, a Tumor Site Activated Synthetic Lethal Therapeutic, in Glioblastoma.

Bachchu Lal, Aditya Kulkarni, Joseph McDermott

|Jan 30, 2023
Topical SCD-153, a 4-methyl itaconate prodrug, for the treatment of alopecia areata.

Jerry Tsai, Sadakatali Gori, Jesse Alt

|Nov 16, 2022
Discovery of DRP-104, a tumor-targeted metabolic inhibitor prodrug.

Rana Rais, Kathryn M Lemberg, Lukáš Tenora

Pageof 1